Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: Findings from the 52-week CANTATA-M study

  • Kaj Stenlöf
  • , William T. Cefalu
  • , Kyoung Ah Kim
  • , Esteban Jodar
  • , Maria Alba
  • , Robert Edwards
  • , Cindy Tong
  • , William Canovatchel
  • , Gary Meininger

Research output: Contribution to journal › Article › peer-review

156 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: Findings from the 52-week CANTATA-M study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science